5-FU and mismatch repair deficient colorectal cancer: Is it time to consider a change in practice?

Colorectal Disease

Volumn 12, Issue 7, 2010, Pages 706-707

  Newton, K ^a   Hill, J ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; IRINOTECAN; K RAS PROTEIN; OXALIPLATIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL PRACTICE; COLORECTAL CANCER; DISEASE COURSE; DISEASE FREE SURVIVAL; GENE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; IMMUNOHISTOCHEMISTRY; MISMATCH REPAIR; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT ABORTION; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SURVIVAL; TREATMENT RESPONSE;

ANTIMETABOLITES, ANTINEOPLASTIC; BASE PAIR MISMATCH; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FLUOROURACIL; HUMANS;

EID: 77952497762     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2010.02220.x     Document Type: Article

References (8)

1. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tosmey PC, Glick JH. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990; 322: 352-8.
2. Des Guetz G, Schischmanoff O, Nicolas P, Perret GY, Morere JF, Uzzan B. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis Eur J Cancer 2009; 45: 1890-6.
3. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005; 23: 609-18.
4. Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Balaguer F, Sempere L, Xicola RM, Bujandra L, Rene J. The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status. Eur J Cancer 2009; 45: 365-73.
5. Available at: http://www.cebm.net/?o=1025.
6. Scottish Intercollegiate Guidelines Network (2002) SIGN 50. A Guideline Developer's Handbook. Scottish Intercollegiate Guidelines Network, Edinburgh.
7. Barrow EJ, Brierly E, Wallace J, Evans A, Hill DG, MacMahon JR. Semiquantative assessment of immunohistochemical staining for mismatch repair proteins in Lynch syndrome. Histopathology in press.
8. Barrow E, McMahon R, Evans DG, Levine E, Hill J. Cost analysis of biomarker testing for mismatch repair deficiency in node-positive colorectal cancer. Br J Surg 2008; 95: 868-75.